Pableo, Mayflor .
HRN: 21-66-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2025
CEFUROXIME 1.5GM (VIAL)
01/09/2025
01/10/2025
IVT
1.5grams
Q8
UTI In Pregnancy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes